Background: The coronavirus disease 2019 (COVID-19) pandemic caused significant disruptions to health care services and health impacts on patients with atopic dermatitis (AD) and/or food allergy (FA).
Objective: We evaluated the impact of the COVID-19 pandemic and disease on AD/FA patients.
Methods: A comprehensive systematic literature search was conducted from December 2019 to 2022.